Kestra Advisory Services’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIX
Kestra Advisory Services's ANIX Position: Q3 2026 in Review
Kestra Advisory Services increased its Anixa Biosciences (ANIX) stake by 6.6% in Q3 2026, buying an estimated $8.04K and bringing the position to 40,500 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3335.
Kestra Advisory Services first reported a position in ANIX in Q4 2024 and has held it in 8 quarters since. The position peaked at $132K in Q1 2026. 55 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.
- Kestra Advisory Services held 40,500 shares of Anixa Biosciences worth $119K as of Q3 2026.
- Kestra Advisory Services bought 2,500 Anixa Biosciences shares in Q3 2026, an estimated $8.04K.
- Anixa Biosciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3335 holding.
- Kestra Advisory Services first reported a position in Anixa Biosciences in Q4 2024 and has held it in 8 quarters since.
- Kestra Advisory Services's Anixa Biosciences position peaked at $132K in Q1 2026.
- 55 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.